EU Vaccine Strategy
Datum der Veranstaltung: 07/01/2021
Vaccines are a key part of a long-term strategy to bring SARS-CoV-2 under control. It is essential to rollout vaccination rapidly to protect as many people as possible and to lower the opportunities for the virus to evolve further. Any vaccine must be authorised by the European Medicines Agency (EMA).
The European Commission has secured up to 2,6 billion doses of vaccines so far and the vaccination in the EU is progressing. However, countries are facing challenges around the limited vaccine supply, disinformation or vaccine acceptance. The European Parliament is trying to keep an eye on the purchase and safety of these vaccines. In the meantime, the EU is also preparing the Digital Green Certificate to facilitate the safe free movement of citizens within the EU during the pandemic. The certificate could include information on whether a traveller has been vaccinated against COVID-19, a COVID-19 test result, and information on recovery from a COVID-19 infection. It should be based on a strict respect for non-discrimination and of the fundamental rights of EU citizens. The legislation should be adopted in the EP by June.
Members of the EP Committee on the Environment, Public Health and Food Safety (ENVI) have an exchange of views with Stella KYRIAKIDES, Commissioner for Health and Food Safety in the morning and an exhange of views with the World Health Organization, in the afternoon.
Members of the EP Committee on Civil Liberties, Justice and Home Affairs have an exchange of views with the Commission on COVID-19 digital certificate
During the plenary session (24-25 March 2021) in the European Parliament in Brussels, MEPs debate on the Digital Green Certificate
Members of the Committee on Budgetary Control (CONT) meet in the European Parliament in Brussels to discuss on the update of advance purchase agreement of vaccines against COVID-19.
Members of the Committee on the Environment, Public Health and Food Safety (ENVI) have an exchange of views with Ms Emer Cooke, Executive Director of the European Medicines Agency, on the update of evaluation and authorisation of COVID-19 vaccines, in the European Parliament in Brussels
Members of the Environment, Public Health and Food Safety (ENVI) Committee have an exchange of views with EMA, ECDC and WHO on COVID variants and the vaccines' efficacy against them.
Members of Committee on Environment, Public Health and Food Safety (ENVI) and Committee on Industry, Research and Energy (ITRE) participate in a joint meeting in the European Parliament in Brussels.
MEPs are expected to reiterate their support for a united EU approach to COVID-19 vaccines in a debate with Commission President von der Leyen.
Presentation by Sandra GALLINA, Director General for Health and Food Safety, DG SANTE, European Commission
MEPs discuss during a meeting of the Committee on the Environment, Public Health and Food Safety
MEPs debate the need for more clarity and transparency regarding vaccine contracts, authorisation, availability and deployment of COVID-19 vaccines.